US Oncology - Rocky Mountain Cancer Centers - Midtown — Denver, Colorado

US Oncology - Rocky Mountain Cancer Centers - Midtown is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

US Oncology - Rocky Mountain Cancer Centers - Midtown has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, Renal Cell Carcinoma, Pancreatic Ductal Carcinoma.

Sponsors: Stemline Therapeutics, Inc., AVEO Pharmaceuticals, Inc., Halozyme Therapeutics.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology - Rocky Mountain Cancer Centers - Midtown?

US Oncology - Rocky Mountain Cancer Centers - Midtown has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology - Rocky Mountain Cancer Centers - Midtown conducted?

US Oncology - Rocky Mountain Cancer Centers - Midtown has 3 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Renal Cell Carcinoma, Pancreatic Ductal Carcinoma.

Is US Oncology - Rocky Mountain Cancer Centers - Midtown accredited by Crixeo Health?

US Oncology - Rocky Mountain Cancer Centers - Midtown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology - Rocky Mountain Cancer Centers - Midtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.